Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Drug Transport and Resistance Mechanisms

TopicLeading institutions, researchers & key papers

This cluster of papers explores the mechanisms of multidrug resistance in cancer, focusing on the role of ATP-dependent transporters, P-glycoprotein, bile acids, ABC transporters, and drug efflux pumps. It also delves into the involvement of nuclear receptors, metabolic regulation, and the impact on intestinal barrier function.

307
Works

How has Drug Transport and Resistance Mechanisms's publication output changed over time?

ScholarIQpublication output · 2003–2022

Output grew0% over the shown period — from 1 works in 2003 to 1 in 2022.

1
1
2
1
1
1
1
2
1
1
2003200520062007201320142015201720182022

What are the most-cited papers on Drug Transport and Resistance Mechanisms?

ScholarIQmost cited works
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Wei Jia, Wei Jia, Guoxiang Xie, Weiping Jia, Weiping Jia
S120397320. 20171,907 CitationsOPEN ACCESS
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
Jasper Smit, Alfred H. Schinkel, Ronald P.J. Oude Elferink, Albert K. Groen, Els Wagenaar, Liesbeth van Deemter, Carla A.A.M. Mol, R. Ottenhoff, Nathalie M. T. van der Lugt, Marian A. van Roon, Martin A. van der Valk, G. J. A. Offerhaus, Anton Berns, Piet Borst
S110447773. 19931,468 Citations
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Stephanie L. Collins, Jonathan G. Stine, Jordan E. Bisanz, C. Denise Okafor, Andrew D. Patterson
S56802129. 20221,123 Citations
Cholesterol gallstone disease
Piero Portincasa, Antonio Moschetta, Giuseppe Palasciano
The Lancet. 2006761 Citations
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
Fei Li, Changtao Jiang, Kristopher W. Krausz, Yunfei Li, István Albert, Haiping Hao, Kristin Fabre, James B. Mitchell, Andrew D. Patterson, Frank J. Gonzalez
Nature Communications. 2013697 CitationsOPEN ACCESS

Where is Drug Transport and Resistance Mechanisms research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

S1203973201,907
S1104477731,468
S568021291,123
S1144305521,081

TOP FUNDERS

National Science Foundation
NIH
Wellcome Trust
European Research Council
Funder breakdown is a member featureSign up free to unlock

How much of the research on Drug Transport and Resistance Mechanisms is open access?

ScholarIQopen access share
47%OPEN ACCESS
Gold
7%
Green
7%
Hybrid
7%
Bronze
27%
Closed
53%

Related on ScholarIQ

Nonalcoholic Fatty Liver Disease
Paper
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paper
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Paper
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
Paper
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Paper
Bile acids and the gut microbiota: metabolic interactions and impacts on disease
Paper
470M+ articles · free account